Amarantus Bioscience Holdings Stock Profit Margin
AMBS Stock | USD 0.0001 0.00 0.00% |
Amarantus Bioscience Holdings fundamentals help investors to digest information that contributes to Amarantus Bioscience's financial success or failures. It also enables traders to predict the movement of Amarantus Pink Sheet. The fundamental analysis module provides a way to measure Amarantus Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amarantus Bioscience pink sheet.
Amarantus |
Amarantus Bioscience Holdings Company Profit Margin Analysis
Amarantus Bioscience's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, Amarantus Bioscience Holdings has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
All Next | Launch Module |
Amarantus Fundamentals
Current Valuation | 6.59 M | |||
Shares Outstanding | 68.27 M | |||
Price To Earning | (0.01) X | |||
Price To Book | 53.19 X | |||
EBITDA | (20.79 M) | |||
Net Income | (10.58 M) | |||
Cash And Equivalents | 178 | |||
Total Debt | 20.72 M | |||
Debt To Equity | 0.84 % | |||
Current Ratio | 0.02 X | |||
Book Value Per Share | (0.12) X | |||
Cash Flow From Operations | (1.8 M) | |||
Earnings Per Share | (0.03) X | |||
Target Price | 9.0 | |||
Number Of Employees | 19 | |||
Beta | 1.67 | |||
Market Capitalization | 3.13 M | |||
Total Asset | 3.48 M | |||
Retained Earnings | (104.87 M) | |||
Working Capital | (14.89 M) | |||
Current Asset | 942 K | |||
Current Liabilities | 15.83 M | |||
Z Score | -63.3 | |||
Net Asset | 3.48 M |
About Amarantus Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amarantus Bioscience Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amarantus Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amarantus Bioscience Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.